Cita APA

De Miguel, R., Delgado Vázquez, R., Rubio García, R., Pulido Ortega, F., & Arribas, J. R. (2020). Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).

Citación estilo Chicago

De Miguel, Rosa, Rafael Delgado Vázquez, Rafael Rubio García, Federico Pulido Ortega, y José Ramón Arribas. Dolutegravir Plus Lamivudine for Maintenance of HIV Viral Suppression in Adults With and Without Historical Resistance to Lamivudine: 48-week Results of a Non-randomized, Pilot Clinical Trial (ART-PRO). 2020.

Cita MLA

De Miguel, Rosa, et al. Dolutegravir Plus Lamivudine for Maintenance of HIV Viral Suppression in Adults With and Without Historical Resistance to Lamivudine: 48-week Results of a Non-randomized, Pilot Clinical Trial (ART-PRO). 2020.